Symbols / NTZ $3.00 -0.66%
NTZ Chart
About
Natuzzi S.p.A., together with its subsidiaries, engages in the design, manufacture, and marketing of leather and fabric upholstered furniture. The company offers stationary furniture, such as sofas, loveseats, and armchairs; sectional furniture; motion furniture; sofa beds; occasional chairs, including recliners and massage chairs; home furnishing accessories, including coffee tables, lamps, rugs, and wall units; and home accessories, which include vases, mirrors, magazines racks, trays, and decorative objects. It also sells polyurethane foam and leather processing by-products. It operates Natuzzi Italia stores; Divani&Divani by Natuzzi stores; and Natuzzi Editions stores. The company offers products through its own and franchised stores in the United States, Italy, China, Brazil, Spain, Mexico, Canada, Australia, Belgium, the United Arab Emirates, South Korea, Israel, Taiwan, the United Kingdom, and internationally. The company was formerly known as Industrie Natuzzi S.p.A. and changed its name to Natuzzi S.p.A. in June 2002. Natuzzi S.p.A. was incorporated in 1959 and is headquartered in Santeramo In Colle, Italy.
Fundamentals
Scroll to Statements| Sector | Consumer Cyclical | Industry | Furnishings, Fixtures & | Market Cap | 33.04M |
| Enterprise Value | 156.42M | Income | -18.65M | Sales | 305.60M |
| Book/sh | 5.69 | Cash/sh | 0.33 | Dividend Yield | — |
| Payout | 0.00% | Employees | 3205 | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | 0.11 | P/B | 0.53 | P/C | — |
| EV/EBITDA | -44.82 | EV/Sales | 0.51 | Quick Ratio | 0.12 |
| Current Ratio | 0.82 | Debt/Eq | 13.74 | LT Debt/Eq | — |
| EPS (ttm) | -1.97 | EPS next Y | — | EPS Growth | — |
| Revenue Growth | -0.80% | Earnings | 2006-09-06 16:00 | ROA | -0.74% |
| ROE | -37.96% | ROIC | — | Gross Margin | 37.11% |
| Oper. Margin | -2.15% | Profit Margin | -6.10% | Shs Outstand | 11.01M |
| Shs Float | 21.31M | Short Float | — | Short Ratio | 3.85 |
| Short Interest | — | 52W High | 5.50 | 52W Low | 2.15 |
| Beta | 0.63 | Avg Volume | 8.96K | Volume | 7.33K |
| Target Price | — | Recom | None | Prev Close | $3.02 |
| Price | $3.00 | Change | -0.66% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
$3.00
Latest analyst target
3. DCF / Fair value
$40.63
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$3.00
Low
—
High
—
Mean
—
News
RSS: Latest NTZ news- 11 Consumer Discretionary Stocks Moving In Tuesday's Intraday Session - Benzinga ue, 10 Mar 2026 17
- Natuzzi faces NYSE listing deadline after falling below $50M - Stock Titan hu, 05 Feb 2026 08
- Is Natuzzi (NYSE:NTZ) In A Good Position To Deliver On Growth Plans? - simplywall.st Fri, 05 Sep 2025 07
- FDA grants Orphan Drug Designation to Genfit's NTZ for ACLF - marketscreener.com Mon, 09 Mar 2026 17
- Furniture tariffs split industry between heavy importers, domestic brands (RH:NYSE) - Seeking Alpha Fri, 26 Sep 2025 07
- Natuzzi Shareholders Delay Capital Reduction Decision and Ratify Director Appointment - TipRanks ue, 17 Feb 2026 08
- Why Zevra Therapeutics Shares Are Trading Higher By Over 17%; Here Are 20 Stocks Moving Premarket - Benzinga ue, 10 Mar 2026 08
- Earnings call transcript: Natuzzi Q3 2025 sees stock drop amid cost challenges - Investing.com Wed, 17 Dec 2025 08
- symbol__ Stock Quote Price and Forecast - CNN ue, 26 Mar 2024 07
- Natuzzi S.p.A. Announces Dates for Its 2025 Third Quarter and First Nine Months Financial Information and Conference Call - Yahoo Finance Mon, 15 Dec 2025 08
- Notable Monday Option Activity: BBY, JNJ, AMC - Nasdaq Mon, 15 Dec 2025 08
- Elite Designers Join Natuzzi's Ambitious Milan Design Week 2025 Showcase - Stock Titan Fri, 04 Apr 2025 07
- Natalizumab-Associated Progressive Multifocal Leukoencephalopathy After Natalizumab Extended Interval Dosing Therapy in Japan - Neurology® Journals hu, 28 Aug 2025 07
- Natuzzi S.p.A. Reports 2024 Financial Results Amidst Strategic Transformation - TipRanks Wed, 23 Apr 2025 07
- Existing anti-parasitic drug could offer a treatment for Ebola - Boston Children's Answers hu, 08 Aug 2019 07
Insider Transactions
No recent insider transactions.
Financials
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | -36.33K | -36.96K | 419.79K | 1.76M |
| TaxRateForCalcs | 0.21 | 0.21 | 0.21 | 0.27 |
| NormalizedEBITDA | 14.51M | 14.59M | 29.69M | 28.33M |
| TotalUnusualItems | -173.00K | -176.00K | 2.00M | 6.53M |
| TotalUnusualItemsExcludingGoodwill | -173.00K | -176.00K | 2.00M | 6.53M |
| NetIncomeFromContinuingOperationNetMinorityInterest | -15.15M | -16.07M | -540.00K | 3.58M |
| ReconciledDepreciation | 21.19M | 22.37M | 21.65M | 21.37M |
| ReconciledCostOfRevenue | 196.57M | 207.12M | 295.80M | 265.68M |
| EBITDA | 14.33M | 14.41M | 31.68M | 34.86M |
| EBIT | -6.86M | -7.96M | 10.04M | 13.49M |
| NetInterestIncome | -9.37M | -8.33M | -7.67M | -6.56M |
| InterestExpense | 7.84M | 7.11M | 6.47M | 4.72M |
| InterestIncome | 829.00K | 941.00K | 868.00K | 225.00K |
| NormalizedIncome | -15.01M | -15.93M | -2.12M | -1.18M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -15.15M | -16.07M | -540.00K | 3.58M |
| TotalExpenses | 324.34M | 338.08M | 459.61M | 425.21M |
| RentExpenseSupplemental | 1.27M | 1.63M | 785.00K | 1.29M |
| TotalOperatingIncomeAsReported | -6.27M | -9.50M | 8.45M | 4.88M |
| DilutedAverageShares | 11.01M | 11.01M | 11.01M | 10.29M |
| BasicAverageShares | 11.01M | 11.01M | 11.01M | 10.29M |
| DilutedEPS | -1.38 | -1.46 | -0.05 | 0.35 |
| BasicEPS | -1.38 | -1.46 | -0.05 | 0.35 |
| DilutedNIAvailtoComStockholders | -15.15M | -16.07M | -540.00K | 3.58M |
| NetIncomeCommonStockholders | -15.15M | -16.07M | -540.00K | 3.58M |
| NetIncome | -15.15M | -16.07M | -540.00K | 3.58M |
| MinorityInterests | 232.00K | 93.00K | -1.83M | -800.00K |
| NetIncomeIncludingNoncontrollingInterests | -15.38M | -16.16M | 1.29M | 4.38M |
| NetIncomeContinuousOperations | -15.38M | -16.16M | 1.29M | 4.38M |
| TaxProvision | 684.00K | 1.09M | 2.27M | 4.39M |
| PretaxIncome | -14.70M | -15.07M | 3.56M | 8.77M |
| OtherIncomeExpense | 216.00K | 2.72M | 2.35M | 10.09M |
| SpecialIncomeCharges | -727.00K | -32.00K | -429.00K | 4.67M |
| GainOnSaleOfPPE | 3.00K | 4.00K | 157.00K | 2.10M |
| GainOnSaleOfBusiness | 0.00 | 0.00 | 5.03M | |
| OtherSpecialCharges | -312.00K | -635.00K | 1.17M | |
| WriteOff | 730.00K | 36.00K | 1.22M | 1.30M |
| EarningsFromEquityInterest | 389.00K | 2.90M | 356.00K | 3.56M |
| GainOnSaleOfSecurity | 554.00K | -144.00K | 2.43M | 1.87M |
| NetNonOperatingInterestIncomeExpense | -9.37M | -8.33M | -7.67M | -6.56M |
| TotalOtherFinanceCost | 2.36M | 2.16M | 2.07M | 2.07M |
| InterestExpenseNonOperating | 7.84M | 7.11M | 6.47M | 4.72M |
| InterestIncomeNonOperating | 829.00K | 941.00K | 868.00K | 225.00K |
| OperatingIncome | -5.54M | -9.47M | 8.88M | 2.17M |
| OperatingExpense | 121.24M | 122.32M | 155.45M | 151.63M |
| OtherOperatingExpenses | -2.25M | -2.78M | -1.04M | -596.00K |
| OtherTaxes | 5.32M | 5.99M | 8.53M | 12.84M |
| DepreciationAmortizationDepletionIncomeStatement | 14.66M | 13.73M | 13.29M | 13.48M |
| DepreciationAndAmortizationInIncomeStatement | 14.66M | 13.73M | 13.29M | 13.48M |
| SellingGeneralAndAdministration | 103.52M | 105.38M | 134.66M | 125.92M |
| SellingAndMarketingExpense | 44.25M | 44.58M | 77.91M | 73.14M |
| GeneralAndAdministrativeExpense | 59.27M | 60.80M | 56.76M | 52.78M |
| OtherGandA | 8.29M | 9.55M | 8.41M | 7.09M |
| InsuranceAndClaims | 1.22M | 1.35M | 1.60M | 946.00K |
| RentAndLandingFees | 1.27M | 1.63M | 785.00K | 1.29M |
| SalariesAndWages | 48.48M | 48.27M | 45.96M | 43.45M |
| GrossProfit | 115.70M | 112.86M | 164.33M | 153.80M |
| CostOfRevenue | 203.09M | 215.76M | 304.15M | 273.57M |
| TotalRevenue | 318.80M | 328.62M | 468.49M | 427.38M |
| OperatingRevenue | 318.80M | 328.62M | 468.49M | 427.38M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| OrdinarySharesNumber | 55.07M | 55.07M | 55.07M | 54.85M |
| ShareIssued | 55.07M | 55.07M | 55.07M | 54.85M |
| NetDebt | 21.73M | 6.58M | 114.00K | |
| TotalDebt | 99.80M | 102.51M | 98.39M | 110.72M |
| TangibleBookValue | 47.38M | 64.78M | 83.60M | 78.19M |
| InvestedCapital | 96.05M | 109.13M | 134.40M | 135.92M |
| WorkingCapital | -14.92M | -4.93M | 10.24M | 1.70M |
| NetTangibleAssets | 47.38M | 64.78M | 83.60M | 78.19M |
| CapitalLeaseObligations | 57.75M | 62.33M | 51.85M | 57.14M |
| CommonStockEquity | 54.01M | 68.94M | 87.86M | 82.33M |
| TotalCapitalization | 68.19M | 81.10M | 99.34M | 95.91M |
| TotalEquityGrossMinorityInterest | 58.21M | 73.29M | 92.56M | 83.85M |
| MinorityInterest | 4.20M | 4.34M | 4.70M | 1.51M |
| StockholdersEquity | 54.01M | 68.94M | 87.86M | 82.33M |
| GainsLossesNotAffectingRetainedEarnings | 20.66M | 20.45M | 23.29M | 17.45M |
| RetainedEarnings | -21.73M | -6.58M | 9.49M | 10.03M |
| CapitalStock | 55.07M | 55.07M | 55.07M | 54.85M |
| CommonStock | 55.07M | 55.07M | 55.07M | 54.85M |
| TotalLiabilitiesNetMinorityInterest | 260.82M | 265.06M | 276.05M | 306.19M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 102.47M | 110.40M | 95.27M | 107.48M |
| OtherNonCurrentLiabilities | 2.16M | 2.73M | ||
| EmployeeBenefits | 11.65M | 12.39M | 13.06M | 15.59M |
| NonCurrentPensionAndOtherPostretirementBenefitPlans | 11.65M | 12.39M | 13.06M | 15.59M |
| TradeandOtherPayablesNonCurrent | 465.00K | 0.00 | ||
| NonCurrentDeferredLiabilities | 18.82M | 20.93M | 20.26M | 21.16M |
| NonCurrentDeferredRevenue | 17.82M | 19.93M | 19.27M | 20.16M |
| NonCurrentDeferredTaxesLiabilities | 998.00K | 996.00K | 996.00K | 996.00K |
| LongTermDebtAndCapitalLeaseObligation | 61.59M | 65.07M | 52.51M | 60.17M |
| LongTermCapitalLeaseObligation | 47.40M | 52.91M | 41.02M | 46.59M |
| LongTermDebt | 14.19M | 12.15M | 11.48M | 13.58M |
| LongTermProvisions | 7.79M | 9.28M | 9.43M | 10.57M |
| CurrentLiabilities | 158.35M | 154.66M | 180.78M | 198.70M |
| OtherCurrentLiabilities | 268.00K | 36.00K | 66.00K | 691.00K |
| CurrentDeferredLiabilities | 27.65M | 21.88M | 17.12M | 21.21M |
| CurrentDeferredRevenue | 27.65M | 21.88M | 17.12M | 21.21M |
| CurrentDebtAndCapitalLeaseObligation | 38.21M | 37.45M | 45.88M | 50.55M |
| CurrentCapitalLeaseObligation | 10.35M | 9.41M | 10.82M | 10.55M |
| CurrentDebt | 27.86M | 28.03M | 35.06M | 40.01M |
| OtherCurrentBorrowings | 24.53M | 26.00M | 33.31M | 38.79M |
| LineOfCredit | 3.33M | 2.04M | 1.75M | 1.22M |
| CurrentProvisions | 1.87M | 2.35M | 3.11M | 2.84M |
| PayablesAndAccruedExpenses | 90.36M | 92.95M | 114.59M | 123.41M |
| CurrentAccruedExpenses | 18.83M | 17.14M | 25.84M | 27.92M |
| Payables | 71.52M | 75.81M | 88.76M | 95.49M |
| OtherPayable | 16.58M | 23.95M | 28.09M | 25.06M |
| TotalTaxPayable | 2.80M | 3.24M | 3.76M | 4.74M |
| IncomeTaxPayable | 830.00K | 339.00K | 1.87M | 2.74M |
| AccountsPayable | 52.14M | 48.62M | 56.90M | 65.69M |
| TotalAssets | 319.02M | 338.35M | 368.61M | 390.03M |
| TotalNonCurrentAssets | 175.60M | 188.62M | 177.58M | 189.63M |
| OtherNonCurrentAssets | 1.75M | 1.60M | 1.45M | 1.42M |
| NonCurrentPrepaidAssets | 6.12M | 6.40M | 5.78M | 4.56M |
| NonCurrentDeferredAssets | 1.65M | 1.67M | 1.03M | 886.00K |
| NonCurrentDeferredTaxesAssets | 1.65M | 1.67M | 1.03M | 886.00K |
| NonCurrentAccountsReceivable | 118.00K | 297.00K | ||
| InvestmentsAndAdvances | 40.88M | 39.83M | 37.70M | 44.52M |
| LongTermEquityInvestment | 40.88M | 39.83M | 37.70M | 44.52M |
| GoodwillAndOtherIntangibleAssets | 6.63M | 4.16M | 4.25M | 4.15M |
| OtherIntangibleAssets | 4.71M | 2.24M | 2.33M | 2.23M |
| Goodwill | 1.92M | 1.92M | 1.92M | 1.92M |
| NetPPE | 118.57M | 134.96M | 127.26M | 133.81M |
| AccumulatedDepreciation | -277.70M | -289.18M | -274.62M | -258.05M |
| GrossPPE | 396.26M | 424.14M | 401.88M | 391.86M |
| Leases | 24.65M | 27.05M | 22.12M | 20.31M |
| ConstructionInProgress | 229.00K | 1.84M | 1.01M | 159.00K |
| OtherProperties | 5.71M | 5.86M | 7.34M | 7.35M |
| MachineryFurnitureEquipment | 130.37M | 129.93M | 130.01M | 127.17M |
| BuildingsAndImprovements | 99.56M | 101.59M | 83.60M | 81.78M |
| LandAndImprovements | 135.75M | 157.87M | 157.80M | 155.08M |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 |
| CurrentAssets | 143.43M | 149.73M | 191.02M | 200.40M |
| OtherCurrentAssets | 5.07M | 5.37M | 7.97M | 12.31M |
| HedgingAssetsCurrent | 24.00K | 147.00K | 925.00K | 96.00K |
| AssetsHeldForSaleCurrent | 8.77M | 0.00 | 0.00 | |
| Inventory | 62.81M | 62.09M | 70.12M | 80.21M |
| FinishedGoods | 33.79M | 34.45M | 32.65M | 39.12M |
| WorkInProcess | 9.33M | 9.79M | 10.46M | 14.09M |
| RawMaterials | 19.70M | 17.85M | 27.00M | 27.01M |
| Receivables | 46.43M | 48.52M | 57.53M | 54.31M |
| OtherReceivables | 9.56M | 10.13M | 13.23M | 7.43M |
| TaxesReceivable | 4.05M | 5.09M | 5.25M | 5.62M |
| AccountsReceivable | 32.82M | 33.30M | 39.06M | 41.26M |
| AllowanceForDoubtfulAccountsReceivable | -3.66M | -4.26M | -5.60M | -5.33M |
| GrossAccountsReceivable | 36.48M | 37.57M | 44.66M | 46.58M |
| CashCashEquivalentsAndShortTermInvestments | 20.32M | 33.61M | 54.48M | 53.47M |
| CashAndCashEquivalents | 20.32M | 33.61M | 54.48M | 53.47M |
| CashEquivalents | 54.39M | 53.27M | ||
| CashFinancial | 20.32M | 33.61M | 54.48M | 53.47M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| FreeCashFlow | -5.41M | -8.61M | 9.10M | -4.45M |
| RepaymentOfDebt | -15.13M | -19.77M | -14.52M | -14.88M |
| IssuanceOfDebt | 3.31M | 10.91M | 4.04M | 5.87M |
| IssuanceOfCapitalStock | 0.00 | 0.00 | 55.00K | 0.00 |
| CapitalExpenditure | -7.14M | -11.82M | -9.61M | -4.99M |
| EndCashPosition | 16.99M | 31.57M | 52.72M | 52.25M |
| BeginningCashPosition | 31.57M | 52.72M | 52.25M | 46.08M |
| EffectOfExchangeRateChanges | 782.00K | -784.00K | -55.00K | 636.00K |
| ChangesInCash | -15.36M | -20.36M | 527.00K | 5.54M |
| FinancingCashFlow | -12.76M | -15.70M | -13.53M | -2.02M |
| CashFlowFromContinuingFinancingActivities | -12.76M | -15.70M | -13.53M | -2.02M |
| NetOtherFinancingCharges | -149.00K | -135.00K | 4.32M | 779.00K |
| NetCommonStockIssuance | 0.00 | 0.00 | 55.00K | 0.00 |
| CommonStockIssuance | 0.00 | 0.00 | 55.00K | 0.00 |
| NetIssuancePaymentsOfDebt | -12.61M | -15.56M | -17.91M | -2.79M |
| NetShortTermDebtIssuance | -798.00K | -6.70M | -7.42M | 6.21M |
| NetLongTermDebtIssuance | -11.81M | -8.86M | -10.48M | -9.01M |
| LongTermDebtPayments | -15.13M | -19.77M | -14.52M | -14.88M |
| LongTermDebtIssuance | 3.31M | 10.91M | 4.04M | 5.87M |
| InvestingCashFlow | -4.32M | -7.88M | -4.65M | 7.02M |
| CashFlowFromContinuingInvestingActivities | -4.32M | -7.88M | -4.65M | 7.02M |
| NetOtherInvestingChanges | -1.35M | 918.00K | 507.00K | |
| DividendsReceivedCFI | 77.00K | 3.02M | 3.70M | 1.74M |
| NetBusinessPurchaseAndSale | 0.00 | 0.00 | 639.00K | 5.25M |
| SaleOfBusiness | 0.00 | 0.00 | 1.10M | 5.51M |
| PurchaseOfBusiness | 0.00 | 0.00 | -461.00K | -270.00K |
| NetIntangiblesPurchaseAndSale | -1.93M | -1.52M | -1.17M | -1.48M |
| NetPPEPurchaseAndSale | -1.12M | -10.30M | -7.81M | 996.00K |
| SaleOfPPE | 4.08M | 0.00 | 624.00K | 4.51M |
| PurchaseOfPPE | -5.21M | -10.30M | -8.43M | -3.52M |
| OperatingCashFlow | 1.72M | 3.21M | 18.71M | 537.00K |
| CashFlowFromContinuingOperatingActivities | 1.72M | 3.21M | 18.71M | 537.00K |
| TaxesRefundPaid | -292.00K | -2.62M | -4.20M | -4.22M |
| InterestPaidCFO | -6.98M | -5.64M | -5.70M | -4.97M |
| ChangeInWorkingCapital | 6.03M | 3.79M | 30.00K | -13.01M |
| ChangeInOtherWorkingCapital | -857.00K | 169.00K | -5.36M | -1.53M |
| ChangeInOtherCurrentLiabilities | 0.00 | |||
| ChangeInOtherCurrentAssets | 146.00K | 2.46M | 4.30M | -2.69M |
| ChangeInPayablesAndAccruedExpense | 5.11M | -14.21M | -7.76M | 13.05M |
| ChangeInPayable | 5.11M | -14.21M | -7.76M | 13.05M |
| ChangeInInventory | -728.00K | 8.03M | 10.09M | -16.00M |
| ChangeInReceivables | 2.36M | 7.33M | -1.24M | -5.85M |
| OtherNonCashItems | -4.04M | 2.41M | 4.32M | 1.62M |
| AssetImpairmentCharge | 441.00K | 0.00 | 890.00K | 1.19M |
| DeferredTax | 684.00K | 1.09M | 2.27M | 4.39M |
| DeferredIncomeTax | 684.00K | 1.09M | 2.27M | 4.39M |
| DepreciationAmortizationDepletion | 21.19M | 22.37M | 21.65M | 21.37M |
| DepreciationAndAmortization | 21.19M | 22.37M | 21.65M | 21.37M |
| AmortizationCashFlow | 1.57M | 1.04M | 1.03M | 1.09M |
| AmortizationOfIntangibles | 1.57M | 1.04M | 1.03M | 1.09M |
| Depreciation | 19.62M | 21.33M | 20.62M | 20.28M |
| OperatingGainsLosses | 76.00K | -2.03M | -1.85M | -10.22M |
| EarningsLossesFromEquityInvestments | -389.00K | -2.90M | -356.00K | -3.56M |
| NetForeignCurrencyExchangeGainLoss | 355.00K | 748.00K | -1.45M | 454.00K |
| GainLossOnSaleOfPPE | 110.00K | 117.00K | -39.00K | -2.08M |
| GainLossOnSaleOfBusiness | 0.00 | 0.00 | -5.03M | |
| NetIncomeFromContinuingOperations | -15.38M | -16.16M | 1.29M | 4.38M |
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for NTZ
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|